May 21, 2012
CASE CCC IN THE NEWS
Some Doctors Unaware of Long-term Side Effects of Cancer Care
Melanoma Mortality Is Related to Dermatologist Density
MARK YOUR CALENDARS
Cancer Center Scientific Series: Imaging in Cancer
Please mark your calendars for the next installment of the Case CCC Scientific Series on Thursday, May 31 in BRB 105, with reception and presentations from 4-6 pm.
Jim Basilion, PhD will give an introduction and overview of the Cancer Imaging Program, followed by presentations by:
Cheryl Thompson, PhD: Variation in Breast Tissue Gene Expression by Mammographic Density
The presenters are reporting updates on research funded by American Cancer Society IRG Pilot Projects.
These extended conferences feature recent scientific investigation from our members, featuring presentations by investigators who received pilot funding after competitive peer review by the Cancer Center. We encourage you to attend, participate in the dialogue, and learn more about the research of your colleagues.
Caring for Carcinoid Foundation-AACR Grant for Carcinoid Tumor and Pancreatic Neuroendocrine Tumor Research
The Caring for Carcinoid Foundation-AACR Grant for Carcinoid Tumor and Pancreatic Neuroendocrine Tumor Research represents a joint effort to promote and support innovative cancer research. This grant is available to independent junior and senior investigators to develop and study new ideas and approaches that have direct application and relevance to carcinoid tumors or pancreatic neuroendocrine tumors. Proposed research may be in any discipline of basic, translational, clinical or epidemiological cancer research.
Deadline: June 18
Case CCC PRMC Tissue Research Submission Template
The Case CCC PRMC Tissue Research Submission Template is available on the Case CCC website Clinical Research Portal and PRMC website. The tissue research submission template should be used for studies that involve research activities limited to archived or discarded tissue. If you have any questions about the template, please contact David Goldblatt at 216.844.5060, email@example.com and/or Kristin Waite at 216.844.5537, firstname.lastname@example.org.
Remember to acknowledge funding or services provided by the Cancer Center in your research papers and publications: "This research was supported by the Case Comprehensive Cancer Center (P30 CA43703)."
Ohio Neuro-Oncology Consortium Meeting
Drs. Jill Barnholtz-Sloan, Candece Gladson, Lisa Rogers, Steven Rosenfeld, and Andrew Sloan presented data on multiple brain tumor research efforts at the Ohio Neuro-Oncology Consortium (ONOC) meeting in Columbus, Ohio on May 7. Dr. Rogers is leading a study of metabolic syndrome and clinical outcomes for glioblastoma, using patients recruited in the Ohio Brain Tumor Study (OBTS).
Dr. Rosenfeld discussed his recent work on targeting glioma invasiveness through the use of a clinically available rho kinase inhibitor.
Dr. Barnholtz-Sloan also gave on talk on the OBTS, describing the study and what is available for research use. The OBTS is a multi-center research effort lead by Drs. Barnholtz-Sloan and Sloan, with participation from CWRU/UHCMC, Cleveland Clinic, Ohio State University and University of Cincinnati, to investigate the association between "omics", environmental factors, clinical factors and clinical outcomes for all newly diagnosed brain tumor patients.
Drs. Barnholtz-Sloan, Gladsen and Rosenfeld are on the ONOC Board of Directors, as the CWRU/UHCMC and Cleveland Clinic representatives, respectively. Additional presenters at the ONOC meeting from Case CCC were Drs. Alex Huang, James Basilion, Justin Lathia and Quinn Ostrom, MA.
Race for the Place- Join Our Team!
The Race for the Place, an event that benefits the Gathering Place, will be held Sunday, June 3 at Beachwood Place Mall. The Case CCC has created a CaseCCC Trainees team. Click here to join the team or to show your support by making a donation. Contact Lyn Haselton, Case CCC Training Program Manager, at 216.844.5375 or email@example.com for more information.
NEWS FROM NIH
NIH Study Finds Sigmoidoscopy Reduces Colorectal Cancer Rates
Flexible sigmoidoscopy, a screening test for colorectal cancer that is less invasive and has fewer side effects than colonoscopy, is effective in reducing the rates of new cases and deaths due to colorectal cancer, according to research sponsored by the National Cancer Institute, part of the National Institutes of Health. In a study that spanned almost 20 years, researchers found that overall colorectal cancer mortality (deaths) was reduced by 26 percent and incidence (new cases) was reduced by 21 percent as a result of screening with sigmoidoscopy. These results appeared online, ahead of print, on May 21, 2012, in the New England Journal of Medicine, and were presented at Digestive Disease Week, a scientific conference.
NCI CANCER BULLETIN
May 15, 2012
**All events are open to anyone interested in attending
Comparative Effectiveness Research: From All Angles
Pathology Research Seminar Series
Skeletal Research Center
Comparative Effectiveness Research: From All Angles
Cancer Biology Fellow Seminar
Hematology and Oncology Division Research Conference
Immunology Invited Speaker Seminar Series
Molecular Genetics Guest Speaker
Stem Cell Biology and Regenerative Medicine
Molecular Medicine Seminar
Hematology/Oncology Fellows will resume in July.
Cancer Center Seminar Series will resume in September.
Taussig Cancer Institute Grand Rounds
Cancer Center Research in Progress Seminar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Case CCC Scientific Series: Imaging in Cancer
Ca-PRI Annual Meeting: Learning from Our Differences
ADDITIONAL UPCOMING SEMINARS & EVENTS
Cleveland Clinic 2012 Personalized Healthcare Summit
Ninth International Conference of the Society for Integrative Oncology
Biennial Science of Global Prostate Cancer Disparities conference
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES
DOD Lung Cancer Research Program Idea Development Award
Alex's Lemonade Stand Foundation Nursing Grants Program Pathfinder Award: Intermediate Nurse Researcher Grants
NIH BULLETIN – Notices and Funding Opportunities
Notice of Change in Participation of NIH Institutes and Centers in PAS-12-169 Limited Competition: Revision Applications to Advance Evidence-Based Research Related to Protections for Human Subjects (U54)(NOT-OD-12-105)
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.